JLE

Hématologie

MENU

Impact de la maladie résiduelle mesurée en prégreffe de moelle chez les adultes avec leucémie aiguë myéloïde et caryotype monosomal Volume 26, issue 4, Juillet-Août 2020

  • [1] Breems D.A., Van Putten W.L.J., De Greef G.E. Monosomal karyotype in acute myeloid leukemia: better indicator of poor prognosis than a complex karyotype. J Clin Oncol. 2008;26:4791-4797.
  • [2] Cornelissen J.J., Breems D., van Putten W.L.J. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. J Clin Oncol. 2012;30:2140-2146.
  • [3] Morsink L.M., Othus M., Bezerra E.D. Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML. Leukemia. 2020;34:1577-1587.
  • [4] Walter R.B., Gooley T.A., Wood B.L. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol. 2011;29:1190-1197.